The Effect of Ablation Therapy on Barrett's Esophagus
| Status: | Enrolling by invitation |
|---|---|
| Conditions: | Gastrointestinal |
| Therapuetic Areas: | Gastroenterology |
| Healthy: | No |
| Age Range: | 18 - 90 |
| Updated: | 2/14/2018 |
| Start Date: | January 2004 |
| End Date: | January 2022 |
To assess the effect of ablative therapy (Photodynamic Therapy or Radiofrequency ablation )
on Barrett's Esophagus
on Barrett's Esophagus
To assess the effect of ablation therapy on Barrett's esophagus. Proposal Ablation therapy is
an FDA approved treatment to decrease cancer risk in Barrett's esophagus mucosa. This is
being performed in our Barrett's Esophagus Unit on a regular basis. However, the longterm
outcomes of this therapy is not established and there are patients who have been treated who
later re-develop Barrett's mucosa. This study will allow us store tissue samples that can
later be used to assess the effect of ablative therapy on Barrett's esophagus.
an FDA approved treatment to decrease cancer risk in Barrett's esophagus mucosa. This is
being performed in our Barrett's Esophagus Unit on a regular basis. However, the longterm
outcomes of this therapy is not established and there are patients who have been treated who
later re-develop Barrett's mucosa. This study will allow us store tissue samples that can
later be used to assess the effect of ablative therapy on Barrett's esophagus.
Inclusion Criteria:
- Patients who have had or qualify for ablation therapy for treatment of their barrett's
esophagus with high grade dysplasia or early esophageal adenocarcinoma
- Ability to provide informed consent
Exclusion Criteria:
- Eastern Cooperative Oncology Group performance status 3 or 4
- Inability to tolerate endoscopic procedures
- Pregnancy: Females of child-bearing age will be screened with pregnancy test.
We found this trial at
1
site
Click here to add this to my saved trials
